.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Farmers Insurance
Novartis
Cipla
Moodys
Julphar
Harvard Business School
Baxter
US Department of Justice
McKinsey

Generated: July 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022327

« Back to Dashboard
NDA 022327 describes PREVACID 24 HR, which is a drug marketed by Glaxosmithkline Cons and is included in one NDA. It is available from one supplier. Additional details are available on the PREVACID 24 HR profile page.

The generic ingredient in PREVACID 24 HR is lansoprazole. There are fifty-four drug master file entries for this compound. Eighty-five suppliers are listed for this compound. Additional details are available on the lansoprazole profile page.

Summary for NDA: 022327

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 022327

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PREVACID 24 HR
lansoprazole
CAPSULE, DELAYED REL PELLETS;ORAL 022327 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0067-6286 0067-6286-14 1 BOTTLE in 1 CARTON (0067-6286-14) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE
PREVACID 24 HR
lansoprazole
CAPSULE, DELAYED REL PELLETS;ORAL 022327 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0067-6286 0067-6286-28 2 BOTTLE in 1 PACKAGE, COMBINATION (0067-6286-28) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CAPSULE, DELAYED REL PELLETS;ORALStrength15MG
Approval Date:May 18, 2009TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
McKinsey
AstraZeneca
Cerilliant
Cantor Fitzgerald
Cipla
McKesson
Teva
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot